Information

2006/09/20

“China Focus” panel discussion in the BioNetwork 2006

2006/09/11

UK-Sino Venture Capital Forum

2006/07/31

Wall Street Reporter Magazine Inc. interviewed Dr. Ying Luo, COO of GNI and CEO of Shanghai Genomics, as a follow-up of the initial interview in 2004. Dr. Luo described the future direction of Shanghai Genomics and GNI.

2006/05/18

Clinical Trial Methods and Models of Asia at Singapore

2006/05/17

Post Genomics Summit 2006

2006/05/14

Chinese Biopharmaceutical Association 2006

2006/05/04

London- based Financial Times published a half-page article on page 9, “March of the mini-multinational”, claiming that the business operation of GNI and Shanghai Genomics prove that it no longer take great scale to straddle borders.

2006/04/09

BIO2006

2006/03/06

“Gu Bang” receives approval from the Chinese SFDA for sales in China

2006/01/24

Yahoo News and PRWEB reported that Shanghai Genomics and Organon, the human healthcare business unit of Akzo Nobel，are to collaborate on a new research project. The collaboration will initially last for a period of two years.